ProTab Laboratories Funding: How Much Did They Raise & Key Investors

How Much Did ProTab Laboratories Raise?
Funding & Key Investors

ProTab Laboratories has solidified its position within the competitive contract manufacturing landscape, securing a total capital infusion of $350K. This latest financial milestone, characterized by a $350K major strategic investment, underscores the firm's operational maturity and its capacity to scale production capabilities for the global nutritional and dietary supplement markets. By leveraging this influx of resources, the Southern California-based manufacturer is poised to enhance its technical infrastructure and expand its service offerings to meet the rigorous demands of modern health-conscious consumers.

The recent financing round reflects a broader trend of institutional confidence in specialized manufacturing entities that provide end-to-end solutions, from research and development to final packaging. As the company navigates its current growth trajectory, this capital serves as a critical lever for optimizing supply chain efficiencies and maintaining the high-quality standards that have defined its reputation since its inception in 2004.

What is ProTab Laboratories?

ProTab Laboratories

Manufacturing

Health & Nutrition Products

Established in 2004, ProTab Laboratories operates as a premier manufacturing partner for the nutraceutical and dietary supplement industries. The company specializes in the production of tablets, capsules, and powder-based formulations, providing a comprehensive suite of value-added services that include technical support, quality control, and custom premix development. By focusing on short lead times and competitive pricing, ProTab has successfully carved out a niche as a reliable partner for brands seeking to accelerate their time-to-market. Their facility in Southern California is equipped to handle complex manufacturing requirements, including specialized packaging solutions for sensitive products such as infant formula, thereby demonstrating a versatile and robust operational framework.

How much funding has ProTab Laboratories raised?

ProTab Laboratories has raised a total of $350K across 1 funding round:

2020

Debt

$350K

Debt (2020): $350K with participation from PPP

Key Investors in ProTab Laboratories

PPP

Public-Private Partnership

What's next for ProTab Laboratories?

With the successful acquisition of this latest investment, ProTab Laboratories is strategically positioned to transition into a phase of accelerated industrial expansion. The company is expected to prioritize the modernization of its manufacturing facilities, potentially integrating advanced automation technologies to further reduce lead times and enhance production precision. Furthermore, the capital will likely support the scaling of its R&D capabilities, allowing the firm to offer more sophisticated formulation services to its growing client base. As the demand for high-quality, transparently sourced nutritional products continues to rise, ProTab is well-equipped to capitalize on these market shifts, ensuring long-term sustainability and continued dominance in the contract manufacturing sector.

See full ProTab Laboratories company page

See More Financial Insights